Vietnamese authorities have expressed their keen interest in enhancing collaboration in the field of medical research and development. They also aim to expand the availability of Russian pharmaceutical products and medical equipment not only in their domestic market but also across Southeast Asia.
Saint Petersburg Institute of Vaccines and Sera of the FMBA of Russia (SPbSRIVS) is currently engaged in a proactive effort to engineer vaccines tailored to address the unique health requirements of Southeast Asian nations. It is with great enthusiasm that they express their readiness to collaborate with Ho Chi Minh City in this crucial endeavor. Furthermore, not only have the city’s pharmaceutical companies, Biocad and Polisan, been collaborating with the Ho Chi Minh Cancer Center for the past five years, but they also possess immense potential to further enhance their partnership.